Search

Your selection

Clear all

Filter by content type

Filter by content year

News

Vaxart Reports Third Quarter 2020 Financial Results and Provides Business Update

November 12, 2020 - …     1,990   Intangible assets, net     15,794     17,093   Total assets   $ 154,710   $ 37,032                 … 16,332   Operating lease liabilities     2,731     2,313   Total liabilities     23,032     24,080   Stockholders’ equity     131,678     12,952   Total liabilities and stockholders’ equity   $ 154,710   $ …
News

Vaxart Announces Additional Data from Hamster Challenge Study of its Oral COVID-19 Vaccine

November 12, 2020 - … contrast, the unvaccinated animals lost approximately 9% total weight. Additionally, unvaccinated hamsters had over … contrast, the unvaccinated animals lost approximately 9% total weight. Additionally, unvaccinated hamsters had over … contrast, the unvaccinated animals lost approximately 9% total weight. Additionally, unvaccinated hamsters had over …
News

Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies

September 8, 2020 - … the lungs were observed at a very high percentage of the total antibody response.  Immunization with our vaccine … the lungs were observed at a very high percentage of the total antibody response.  Immunization with our vaccine … the lungs were observed at a very high percentage of the total antibody response.  Immunization with our vaccine …
News

Vaxart Announces Second Quarter 2020 Results

August 6, 2020 - …   1,990   Intangible assets, net     16,227       17,093   Total Assets   $ 64,190     $ 37,032                         …   Operating lease liabilities     1,924       2,313   Total liabilities     23,955       24,080   Stockholders’ equity     40,235       12,952   Total liabilities and stockholders’ equity   $ 64,190     $ …
News

Norovirus Gastroenteritis Costs an Estimated $10.6 Billion Each Year in the United States

July 16, 2020 - … United States July 16, 2020 General Over 90% of norovirus' total annual cost is due to sporadic spread in the community. … the results from the new study show that over 50% of the total costs are incurred during winter. This suggests that … In addition, productivity losses accounted for 89% of total costs, offering a sense of how much norovirus may be …
News

Vaxart, Inc. Set to Join Russell 3000® Index

June 24, 2020 - … 4,000 largest U.S. stocks as of May 8 , ranking them by total market capitalization. Membership in the U.S. all-cap … 4,000 largest U.S. stocks as of May 8 , ranking them by total market capitalization. Membership in the U.S. all-cap … 4,000 largest U.S. stocks as of May 8 , ranking them by total market capitalization. Membership in the U.S. all-cap …
News

Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update

May 12, 2020 - …     1,990   Intangible assets, net   16,660     17,093   Total assets $ 52,564   $ 37,032           Liabilities and …   16,332   Operating lease liabilities   2,126     2,313   Total liabilities   21,271     24,080   Stockholders’ equity   31,293     12,952   Total liabilities and stockholders’ equity $ 52,564   $ …
News

Vaxart Announces Corporate Update for First Quarter 2020

April 28, 2020 - … of $29.9 million as of March 31, 2020 . Vaxart received a total of $10.3 million from warrant exercises during the … of $29.9 million as of March 31, 2020 . Vaxart received a total of $10.3 million from warrant exercises during the … of $29.9 million as of March 31, 2020 . Vaxart received a total of $10.3 million from warrant exercises during the …
News

Vaxart Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

March 19, 2020 - … Program, the First Oral Coronavirus Vaccine Raised total of $19.8 Million from a Registered Direct Offering and …   —     Intangible assets, net     17,093       19,413     Total Assets   $ 37,032     $ 35,227                       …     Operating lease liabilities     2,313       —     Total liabilities     24,080       23,989     Stockholders’ …
News

Results from Influenza Challenge Study Published in Lancet Infectious Diseases

January 22, 2020 - … and Development Authority (BARDA). Vaxart received a total of $15.7 million under a contract from BARDA to support … and Development Authority (BARDA). Vaxart received a total of $15.7 million under a contract from BARDA to support … and Development Authority (BARDA). Vaxart received a total of $15.7 million under a contract from BARDA to support …
Scroll to Top